Xylem
$101.79Change from previous close: +0.90%Absolute change: +$0.91
Valuation
Data as of October 5, 2026
Valuation multiples
- Market cap
- $23.77B
- Enterprise value
- $25.55B
- P/E (trailing 12 months)
- 24.2
- Forward P/E
- 17.3
- PEG
- 1.44
- Price/book
- 2.28
- Price/sales
- 2.60
- EV/EBITDA
- 12.9
- EV/revenue
- 2.80
Profitability and growth
- Gross margin
- 39.2%
- Operating margin
- 15.5%
- Net margin
- 11.2%
- ROE
- 9.2%
- ROA
- 5.1%
- ROIC
- 9.0%
Financial health
- Total cash
- $1.28B
- Total debt
- $3.06B
- Debt/equity
- 0.29
- Current ratio
- 1.61
- Quick ratio
- 1.16
- Altman Z-Score
- 4.12
- Piotroski F-Score
- 5.00
Dividends
- Annual dividend per share
- $1.72
- Dividend yield
- 1.7%
- Payout ratio
- 40.9%
- Ex-dividend date
- August 27, 2026
Analysts and estimates
- Average price target
- $153.88
- Analysts with a price target
- 21
- Consensus
- Buy
Shares and trading
- Beta
- 0.99
- Average volume
- 2.86M
- Shares outstanding
- 233.49M
- Float
- 232.88M
- Institutional ownership
- 96.3%
- Insider ownership
- 0.2%
- Short interest (% of float)
- 4.7%
- Short ratio (days)
- 4.77